Type 2 Diabetes News
Most Popular Type 2 Diabetes Story
Roche faces long delay for diabetes drug taspoglutide
Roche has delayed development of its potential blockbuster type 2 diabetes drug taspoglutide for up to 18 months due to hypersensitivity problems observed in trial subjects, including skin reactions Read more...
Latest Headlines
- December 21, 2011
- November 22, 2011
- August 12, 2011
- June 23, 2011
- February 2, 2011
- December 8, 2010
- September 30, 2010
- September 24, 2010
- September 20, 2010
- June 28, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
